Imap

Fluspirilene, the active ingredient in Imap, is a typical antipsychotic presented as an injectable solution for intramuscular use. It is employed to treat schizophrenia by alleviating psychotic symptoms in adult patients.

GNH USA supplies Imap as a licensed, GDP‑compliant international pharmaceutical supplier serving hospitals, pharmacies and clinics worldwide, adhering to stringent quality standards and providing reliable logistics for global distribution. The product meets EU pharmacopeial specifications and is manufactured under GMP conditions. It is available in multiple vial sizes to accommodate varied clinical needs.

Fluspirilene is a typical antipsychotic that acts on dopaminergic pathways to manage schizophrenia.

Schizophrenia: Reduces positive and negative psychotic symptoms, helping stabilize mood and cognition. Acute exacerbations: Controls sudden worsening of psychosis, facilitating rapid symptom control. Maintenance therapy: Supports long‑term symptom stability and reduces relapse risk.

Fluspirilene may be associated with a range of adverse reactions, varying from mild to severe.

Common Side Effects: - Sedation: Drowsiness or reduced alertness. - Extrapyramidal symptoms: Muscle stiffness, tremor, or restlessness. - Dry mouth: Reduced salivation leading to discomfort.

Serious or Rare Side Effects: - Tardive dyskinesia: Involuntary, repetitive movements that may be irreversible. - Neuroleptic malignant syndrome: Life‑threatening reaction with fever, rigidity and autonomic instability. - Severe hypotension: Marked drop in blood pressure causing dizziness or fainting.

When prescribing fluspirilene, clinicians should observe several precautionary measures to ensure patient safety. - Monitor extrapyramidal symptoms: Assess regularly for signs of movement disorders. - Evaluate cardiovascular status: Check blood pressure and heart rate before and during therapy. - Assess metabolic parameters: Periodically measure weight, glucose and lipid levels. - Use caution in hepatic impairment: Adjust therapy if liver function is compromised. - Avoid in patients with known hypersensitivity: Discontinue if allergic reaction occurs. - Store at 2-8°C: Keep refrigerated, protect from light, do not freeze or shake.

Fluspirilene can interact with other medicines, altering its efficacy or safety profile.

Major Interactions (Avoid): - CNS depressants: May enhance sedation and respiratory depression. - QT‑prolonging drugs: Increase risk of cardiac arrhythmias. - MAO inhibitors: Heightened risk of severe hypotension.

Moderate Interactions (Monitor Closely): - Antihypertensives: May potentiate blood pressure lowering effects. - Antidiabetic agents: Possible alteration of glucose control.